"Our staff at Terrebonne General Health System takes pride in being the largest community-based health system in southeast Louisiana. Our hospital has been honored with many prestigious awards and accolades on both the national and international level in recognition of these outstanding healthcare services."

During the past decade, Terrebonne General Medical Center conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 18 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 7 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Terrebonne General Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 14 trials, followed by "Alliance for Clinical Trials in Oncology" with 13 trials sponsored, "Boston Scientific Corporation" with 4 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "Abbott Medical Devices" with 4 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Terrebonne General Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 24 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "American College of Surgeons" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Baim Institute for Clinical Research" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Terrebonne General Medical Center" are "Breast Cancer" (6 trials), "Breast Carcinoma" (3 trials), "Invasive Breast Carcinoma" (3 trials), "Lymphoma" (3 trials) and "Peripheral Vascular Disease" (3 trials). Many other conditions were trialed in "Terrebonne General Medical Center" in a lesser frequency.

Most popular intervention types in "Terrebonne General Medical Center" are "Drug" (31 trials), "Other" (27 trials), "Procedure" (15 trials), "Biological" (12 trials) and "Device" (12 trials). Other intervention types were less common.

The name of intervention was led by "Biospecimen Collection" (12 trials), "Quality-of-Life Assessment" (12 trials), "Questionnaire Administration" (12 trials), "Computed Tomography" (8 trials) and "Paclitaxel" (6 trials). Other intervention names were less common.

The vast majority of trials in "Terrebonne General Medical Center" are 45 trials for "All" genders, 8 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Terrebonne General Medical Center". undefined are not yet recruiting, 14 are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Terrebonne General Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Terrebonne General Medical Center, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".

Terrebonne General Medical Center has several departments that took part in Clinical trials: "Cardiovascular Institute of the South/Terrebonne General" - 2 trials